Catalyst Wire Dossier Catalyst Wire Dossier

IPX054

IPX054 · Impax Laboratories, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IPX054, covering 2019-10-29 to 2019-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease [Phase 2]

See pricing